HighMark Wealth Management’s Bicycle Therapeutics BCYC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.02K | Hold |
435
| – | – | ﹤0.01% | 452 |
|
|
2025
Q1 | $3.69K | Sell |
435
-4,000
| -90% | -$34K | ﹤0.01% | 399 |
|
|
2024
Q4 | $62.1K | Hold |
4,435
| – | – | 0.04% | 109 |
|
|
2024
Q3 | $100K | Hold |
4,435
| – | – | 0.05% | 101 |
|
|
2024
Q2 | $89.8K | Hold |
4,435
| – | – | 0.05% | 106 |
|
|
2024
Q1 | $110K | Hold |
4,435
| – | – | 0.07% | 93 |
|
|
2023
Q4 | $80.2K | Hold |
4,435
| – | – | 0.06% | 105 |
|
|
2023
Q3 | $89.1K | Buy |
4,435
+200
| +5% | +$4.02K | 0.07% | 85 |
|
|
2023
Q2 | $108K | Hold |
4,235
| – | – | 0.08% | 78 |
|
|
2023
Q1 | $90.1K | Hold |
4,235
| – | – | 0.07% | 102 |
|
|
2022
Q4 | $125K | Hold |
4,235
| – | – | 0.09% | 67 |
|
|
2022
Q3 | $99K | Hold |
4,235
| – | – | 0.08% | 70 |
|
|
2022
Q2 | $71K | Hold |
4,235
| – | – | 0.06% | 83 |
|
|
2022
Q1 | $186K | Sell |
4,235
-90
| -2% | -$3.95K | 0.12% | 56 |
|
|
2021
Q4 | $263K | Buy |
4,325
+3,699
| +591% | +$225K | 0.17% | 46 |
|
|
2021
Q3 | $26K | Buy |
+626
| New | +$26K | 0.02% | 161 |
|